Healthcare Triangle (HCTI) AI Stock Analysis

• Market Cap: $3.35M
• Dividend Yield: N/A
• Average Volume (3M): 1.85M
• Price to Earnings (P/E): ―
• Beta (1Y): -0.24
• Revenue Growth: -21.88%
• EPS Growth: 68.40%
• Country: US
• Employees: 36
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): N/A
• Shares Outstanding: 1,155,370
• 10 Day Avg. Volume: 1,253,213
• 30 Day Avg. Volume: 1,845,381
• PEG Ratio: 1.14
• Price to Book (P/B): -60.59
• Price to Sales (P/S): 26.49
• P/FCF Ratio: -286.66
• Enterprise Value/Market Cap: 0.05
• Enterprise Value/Revenue: 0.01
• Enterprise Value/Gross Profit: 0.10
• Enterprise Value/Ebitda: -0.03
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 41 Neutral
• Price Target: $0.25 ▼(-54.63% Downside)
• Action: Upgraded Date: 01/29/26
• Date: Action: Upgraded 01/29/26

The score is weighed down primarily by weak financial performance—deep ongoing losses, margin compression, and heavy negative free cash flow—alongside a strongly bearish price trend below all major moving averages. Corporate actions provide strategic upside via the AI acquisition, but recent convertible/ATM financing introduces dilution risk, and valuation signals are not supportive due to negative earnings.

Positive Factors

Healthcare IT services focus

Healthcare Triangle's core services—cloud migration, data management, interoperability and managed/consulting services—address mission-critical modernization needs across providers, payers and life sciences. These offerings tend to be sticky, support multi-year engagements and align with ongoing digitalization and regulatory trends that sustain demand.

Strategic AI asset acquisition

The Teyame AI asset acquisition introduces AI-powered patient engagement and SaaS capabilities, expanding recurring revenue potential and platform depth. Integrating SaaS/AI products can improve revenue visibility, increase gross margins over time if scaled, and broaden the company’s addressable market toward higher-margin, subscription-driven streams.

Demonstrated access to institutional capital

Closing a convertible note tranche shows the company can tap institutional financing to fund growth, acquisitions, and working capital while cash flows remain negative. Reliable access to capital is a durable operational enabler that can preserve runway for strategic investments until operating cash generation improves.

Negative Factors

Severe cash burn

Persistent negative operating and free cash flow materially constrains reinvestment capacity and forces ongoing reliance on external financing. Over multiple quarters this undermines financial flexibility, raises refinancing and survival risk, and limits ability to fund product development or scale sales until cash generation reverses.

Deteriorating profitability and margins

Sharp gross margin compression and deeply negative net margins indicate weak unit economics and limited operating leverage. Sustained losses reduce the firm’s ability to self-fund growth, pressure returns on invested capital, and suggest structural issues in pricing, cost control, or product mix that must be resolved for durable profitability.

Dilution and financing overhang risk

Board-authorized capacity to issue large amounts of securities, together with ATM programs and convertible notes, creates meaningful dilution and market overhang risk. Repeated equity-capital reliance signals persistent funding gaps and can reduce long-term shareholder returns and deter long-term investor confidence absent a clear path to positive cash flow.

Healthcare Triangle Business Overview & Revenue Model

Company Description

Healthcare Triangle, Inc., a healthcare information technology company, focuses on developing solutions in the sectors of cloud services, data science, and professional and managed services. It provides a suite of software, solutions, platforms, and services that enables healthcare and pharma organizations to deliver personalized healthcare, precision medicine, advances in drug discovery, development and efficacy, collaborative research and development, respond to evidence, and enhance the digital transformation. The company's software platforms include CloudEz, an enterprise multi-cloud transformation and management platform that enables customers to manage their cloud infrastructure across private, hybrid, and public cloud infrastructures; and DataEz, a cloud-based data analytics and data science platform for the data analytics and data science requirements of life sciences/pharmaceutical and healthcare provider organizations. It also provides Readabl.AI, a Software-as-a-Service solution that uses public cloud artificial intelligence and machine learning to recognize and extract healthcare information from documents, faxes, and narrative reports. In addition, it offers cloud IT services; and healthcare IT services, such as electronic health records and software implementation, optimization, and extension to community partners, as well as application managed services, and backup and disaster recovery on public cloud. The company primarily serves healthcare delivery organizations, healthcare insurance companies, pharmaceutical and life sciences, biotech companies, and medical device manufacturers. Healthcare Triangle, Inc. was incorporated in 2019 and is based in Pleasanton, California. Healthcare Triangle, Inc. operates as a subsidiary of SecureKloud Technologies, Inc.

How the Company Makes Money

Healthcare Triangle generates revenue primarily through its comprehensive suite of cloud and data services offered to healthcare providers, payers, and life sciences companies. The company makes money by delivering subscription-based cloud services, consulting fees for data analytics and transformation projects, and managed services contracts. Additionally, HCTI partners with major cloud providers like AWS, Google Cloud, and Microsoft Azure, which enhances its service offerings and expands its market reach. These strategic partnerships, along with a focus on innovation and compliance with healthcare regulations, are significant factors contributing to its earnings.

Healthcare Triangle Financial Statement Overview

Summary

Despite TTM revenue growth (+9.1%), fundamentals are dominated by persistent losses (TTM net margin -48.9%), sharply lower gross margin (13.1% TTM vs. 24.7% in 2024), and severe cash burn (TTM operating cash flow -$11.0M; free cash flow -$12.3M). Leverage is currently moderate (debt $1.53M vs. equity $8.74M), but equity volatility (negative equity in 2024) and consistently weak returns heighten financing/dilution risk.

Income Statement

TTM (Trailing-Twelve-Months) revenue is up (9.1%), but profitability remains weak: gross margin has compressed sharply (13.1% TTM vs. 24.7% in 2024), while net results are deeply negative (net margin -48.9% TTM). Losses have persisted for several years (net income negative from 2021–TTM) and operating profitability is also materially negative, indicating limited operating leverage and ongoing pressure on the underlying business model.

Balance Sheet

Leverage looks moderate in the latest period with total debt of $1.53M against $8.74M of equity (TTM), and debt has come down versus 2023–2024 levels. However, the balance sheet profile has been volatile: equity was negative in 2024, and returns on equity are consistently weak/negative in most periods, reflecting ongoing losses and potential dilution/recapitalization risk even if headline debt is currently manageable.

Cash Flow

Cash generation is the key weakness. TTM (Trailing-Twelve-Months) operating cash flow is deeply negative (-$11.0M) with negative free cash flow (-$12.3M), signaling significant cash burn and reliance on external funding. While free cash flow growth is shown as improving, the absolute level remains very negative and materially worse than 2024, increasing near-term liquidity and financing risk.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	12.94M	11.70M	33.20M	45.89M	35.27M	31.34M
Gross Profit	1.70M	2.89M	6.78M	11.29M	10.52M	8.59M
EBITDA	-5.07M	-3.85M	-4.10M	-5.96M	-3.94M	1.98M
Net Income	-6.32M	-5.97M	-12.34M	-9.61M	-5.95M	2.35M
Balance Sheet
Total Assets	13.84M	1.96M	10.05M	20.76M	24.61M	11.11M
Cash, Cash Equivalents and Short-Term Investments	1.63M	20.00K	1.23M	1.34M	1.77M	1.40M
Total Debt	1.53M	2.65M	4.32M	2.41M	3.45M	754.40K
Total Liabilities	5.11M	7.08M	9.51M	8.38M	8.48M	6.78M
Stockholders Equity	8.74M	-5.11M	538.00K	12.39M	16.13M	4.33M
Cash Flow
Free Cash Flow	-12.26M	-1.08M	-1.63M	-5.92M	-10.24M	-734.67K
Operating Cash Flow	-10.97M	-1.08M	-1.61M	-2.60M	-7.11M	-734.67K
Investing Cash Flow	-1.29M	0.00	-13.00K	-3.32M	-7.63M	-477.46K
Financing Cash Flow	13.86M	-133.00K	1.52M	5.49M	15.11M	1.64M

Healthcare Triangle Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.54
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HCTI, the sentiment is Negative. The current price of 0.54 is below the 20-day moving average (MA) of 7.60, below the 50-day MA of 27.14, and below the 200-day MA of 426.85, indicating a bearish trend. The MACD of -7.37 indicates Negative momentum. The RSI at 15.21 is Positive, neither overbought nor oversold. The STOCH value of 3.35 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HCTI.

Healthcare Triangle Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
BEAT	43 Neutral	$61.38M	-2.70	-792.01%	―	―	4.31%
HCTI	41 Neutral	$3.35M	-0.44	-182.56%	―	-21.88%	68.40%
MSPR	40 Underperform	$470.22K	-2.13	―	―	-8.57%	-52.17%
VSEE	38 Underperform	$13.10M	-8.71	―	―	187.24%	82.90%

Healthcare Triangle Corporate Events

Healthcare Triangle Completes AI Customer Experience Acquisition

On January 22, 2026, Healthcare Triangle entered into a Share Purchase Agreement via its subsidiary Teyame AI Holdings to acquire all equity interests in Spain-based Teyamé 360 S.L. and Datono Mediación S.L., leaders in AI-powered omnichannel customer experience solutions, with the transaction closing on January 29, 2026 and deemed effective as of January 1, 2026. The deal values the acquired companies at up to $50 million in a mix of staged cash payments, restricted common stock, non-voting convertible preferred stock, and a performance-based earnout in preferred shares for key managers, while incorporating price-adjustment mechanisms, shareholder-approval conditions on conversion, and structural limits on common share issuance. According to financial information from Teyame, the acquired assets generated about $32 million in incremental revenue and $3.6 million in EBITDA for 2025 and are projected to add $38 million in next-twelve-month revenue and $5 million in EBITDA, marking a strategic pivot for Healthcare Triangle toward AI-driven, global SaaS patient and customer engagement, with an expanded footprint in Europe and Latin America and a deeper integration of Agentic Generative AI into its healthcare technology stack.

The most recent analyst rating on (HCTI) stock is a Hold with a $0.28 price target. To see the full list of analyst forecasts on Healthcare Triangle stock, see the HCTI Stock Forecast page.

Healthcare Triangle Announces Acquisition of Teyame AI Assets

On December 10, 2025, Healthcare Triangle, Inc. announced an Advance Agreement for the acquisition of Teyame AI LLC’s assets, including Teyame 360 SL and Datono Mediacion SL, which are leaders in AI-powered customer experience solutions. This acquisition, expected to close in the first quarter of 2026, aims to enhance Healthcare Triangle’s position as a global leader in AI-driven patient engagement, potentially generating $34 million in annual revenue and $4.2 million in EBITDA for fiscal year 2025. The strategic move is part of Healthcare Triangle’s broader strategy to expand its AI-driven healthcare innovation and global SaaS platforms, creating an integrated ecosystem for intelligent patient engagement.

Healthcare Triangle Approves $70 Million Securities Issuance

On November 28, 2025, Healthcare Triangle, Inc. held a virtual Special Stockholders Meeting where stockholders approved a proposal to issue up to $70 million in securities over the following three months, in accordance with Nasdaq Listing Rule 5635(d). This approval, achieved with a majority vote, allows the company to pursue future issuances within specified Nasdaq parameters, potentially impacting its financial strategy and market positioning.

Healthcare Triangle Secures $15M in Convertible Notes

On November 20, 2025, Healthcare Triangle, Inc. entered into a Securities Purchase Agreement with institutional investors to issue senior unsecured convertible promissory notes totaling up to $15 million. The initial tranche of $7.5 million was closed on the same date, with the company receiving $6 million after a 20% discount. The notes, which mature in 2026, are convertible into common stock and rank senior to future company debts. This financial move is significant for Healthcare Triangle as it secures immediate capital and positions the company for potential growth, while also obligating it to meet specific registration and conversion conditions that could impact its stockholder relations and market operations.

Healthcare Triangle Enters Sales Agreement with Spartan Capital

On November 18, 2025, Healthcare Triangle, Inc. entered into a Sales Agreement with Spartan Capital Securities, LLC to facilitate an ‘at the market offering’ of its common stock, with a market value of up to $20,000,000. This agreement allows the company to sell shares directly on the Nasdaq Capital Market or other trading platforms, providing flexibility in raising capital while Spartan receives a 3% commission on sales, enhancing the company’s financial strategy and market presence.

Healthcare Triangle Holds Virtual Annual Shareholder Meeting

On November 7, 2025, Healthcare Triangle, Inc. held its virtual annual meeting of shareholders, where four directors were elected for a one-year term, and SRCO Professional Corporation was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2025. Approximately 82.80% of the company’s shares were represented at the meeting, reflecting strong shareholder engagement. These decisions are expected to influence the company’s governance and financial oversight positively, potentially impacting its strategic direction and stakeholder confidence.